Global Youth Coalition on HIV/AIDS - Groups - Action Tools

Message

From:	moses okpara [ profile ]
Subject:	call for abstracts regional education summit
Sent:	Aug 11th, 2011 - 13:20:32

	pls circulate widely kindly find the information below useful in both english and french RESHAA 2011 Call for abstract The 1st Regional Education Summit on HIV & AIDS in Africa, welcomes the submission of abstracts in the following tracks: 1. TRACK A: Policy and Coordination 2. TRACK B: Workplace Initiative 3. TRACK C: Prevention Education using School Based Approach 4. TRACK D: Informal Education 5. TRACK E: Research and Monitoring/Evaluation 6. TRACK F: Integration into other developmental issues Submission guidelines 1. All abstracts must be written in English and /or French. Texts written in other alphabets cannot be saved by the submission system. 2. Abstracts should disclose primary findings and avoid, whenever possible, promisory statements such as “experiments are in progress” or “results will be discussed”. 3. Abstracts can only be submitted online via the Summit website www.reshaa2011.org. Important Dates 01 August 2011 Online abstract submission opens 31 August 2011 Abstract submission closes 11.59GMT. 01 September 2011 Late breaker abstracts submission opens 15 September 2011 Late breaker abstracts submission closes 11.59GMT. For further enquiry visit our website at www.reshaa2011.org french version SREVSA 2011, ABUJA Appel d’Abstraits Le1er Sommet Régional de l’Éducation sur VIH & SIDA en Afrique, SREVSA 2011 accueille la soumission des abstraits sur tous les traces suivants : 1. Trace A:Politique et Coordination 2. Trace B:Initiative du lieu de travail 3. Trace C:Éducation préventive en utilisant l'approche scolaire 4. Trace D:Éducation informelle 5. Trace E: Recherche et Surveillance/Evaluation 6. Trace F: Intégration dans d'autres enjeux de développement Les Directives de la Soumission * Tous les abstraits doivent être rédigés en anglais ou en français. Les textes écrits dans d'autres alphabets ne peuvent pas être sauvé par le système de soumission. * Tous les abstraits doivent révéler les recherches principales et éviter, autant que possible, des déclarations de promesse telles que "les expériences sont en cours" ou "les résultats seront discuté". * Les abstraits doivent être soumis en ligne via le site de la conférencewww.reshaa2011.org. Dates Importantes 01 Août 2011 L’ouverture de la soumission des abstraits 31 Août 2011 La fermeture de la soumission des abstraits 11.59GMT. 01 Septembre 2011 L’ouverture de la soumission des abstraits pour les retardataires 15 Septembre 2011 La fermeture de la soumission des abstraitspour les retardataires 11.59GMT. Veuillez visiter le site sur www.reshaa2011.org pour plus de renseignement ________________________________ From: Global Youth Coalition on HIV/AIDS To: moses okpara Sent: Thursday, August 11, 2011 9:02 AM Subject: [GYCA] Daily Digest for August 10, 2011 (6 msgs) Welcome to your Daily Digest for the 'Global Youth Coalition on HIV/AIDS' group! If you wish to e-mail the group, reply to this message or send an e-mail to: GYCA (at) tiggroups.org Here's a summary of yesterday's messages from the group: 1 -> Fwd: HIV Young Leaders Fund and Youth LEAD: Request for Proposals inSoutheast Asia and the Pacific. (Lindsay Menard-Freeman) 2 -> HIV/AIDS: Adult male circumcision – new developments ("Makona, Edgar Dearn") 3 -> Coming soon: An improved, noiseless female condom (Gabriel ADEYEMO) 4 -> TED: Hans Rosling on the HIV epidemic (joya banerjee) 5 -> Help Dr. Arash Alaei and his brother Dr. Kamiar Alaei are renownedHIV/AIDS physician ("John Piermont V. Montilla") 6 -> FW: Pregnancy increases risk of HIV : Message from Melanie Pleaner (joya banerjee) You can view full message texts below! -----> Message 1 From: Lindsay Menard-Freeman Subject: Fwd: HIV Young Leaders Fund and Youth LEAD: Request for Proposals inSoutheast Asia and the Pacific. Attachments: Please see information about this opportunity below. ---------- Forwarded message ---------- From: Caitlin Chandler Date: Fri, Aug 5, 2011 at 6:35 PM Subject: HIV Young Leaders Fund and Youth LEAD: Request for Proposals in Southeast Asia and the Pacific. To: HIV Young Leaders Fund, in collaboration with Youth LEAD, is happy to announce our Request for Proposals for youth-led initiatives working to address the needs of young people most-affected by HIV in Southeast Asia and the Pacific. Eligibility and Criteria Organizations in the following countries are eligible to apply: Cambodia, Indonesia, Papua New Guinea, Philippines, Thailand and Vietnam. Applicants must be youth-led initiatives coordinated and governed by young people aged 30 years or younger. We support the following priority areas: advocacy, peer-based services and community mobilization. Applicants can apply for up to $10,000 usd. For full guidelines and eligibility criteria, please see the attached Request for Proposals. Language Applications may be submitted in: English, Indonesian, Khmer, Thai and Vietnamese. Non-English application materials will be available shortly - please contact GrantApplication (at) hivyoungleadersfund.org to request a copy in another language or visit our website, www.hivyoungleadersfund.org. * * To Apply To apply, please fill out the attached Grant Application and Budget Template and submit to: GrantApplication (at) hivyoungleadersfund.org. The deadline for all applications is September 15, 2011 at 11 pm GMT. Grant Decisions Grant decisions will be made through a regional Community Review Panel (CRP) composed of young leaders with experience in youth HIV issues in the Southeast Asia and the Pacific region. Grantees will have access to mentorship and support from HYLF, Youth LEAD, and our partners. Please help us spread the word about this opportunity! Best wishes, The HYLF & Youth LEAD Teams --- HYLFs mission is to enable new leadership in the HIV response among young people most-affected by HIV, including young people living with HIV. HYLFs Steering Committee selected Southeast Asia and the Pacific as one of HYLFs priority regions for 2011-2012. Youth LEAD is a network of young key affected populations in the Asia-Pacific region housed by Seven Sisters and is HYLF's regional partner. HYLFs work in Southeast Asia and the Pacific has been made possible by the generous support of ViiV Healthcares Positive Action programme and the United Nations Population Fund. HYLF is project of Tides Center. The following organizations sit on HYLF's Steering Committee: Association of Positive Youth in Nigeria, Global Network of Sex Work Projects, Global Youth Coalition on HIV/AIDS, Global Network of People Living with HIVs Y+ Programme, International Gay, Lesbian, Transgender and Queer Youth and Student Organisation, International Treatment Preparedness Coalition, Jamaica Youth Advocacy Network, World AIDS Campaign, Youth Coalition for Sexual and Reproductive Rights, Y-PEER, and Youth R.I.S.E. * * * * www.hivyoungleadersfund.org -- Lindsay Menard-Freeman Program Officer Global Youth Coalition on HIV/AIDS, a program of TakingITGlobal www.gyca.org www.tigweb.org (T): +212.661.6111 (E): lindsay (at) gyca.org 540 President St. 3rd Floor Brooklyn, NY 11215 Donate now! http://tigurl.org/gycadonate/ GYCA is a youth-led global network of over 5,500 young leaders and adult allies working on youth and HIV/AIDS in 173 countries world-wide. GYCA's mission is to empower young leaders with the skills, knowledge, resources and opportunities they need to scale up HIV/AIDS interventions amongst their peers.-----> Message 2 From: "Makona, Edgar Dearn" Subject: HIV/AIDS: Adult male circumcision – new developments Medical male circumcision has been a World Health Organization (WHO)-endorsed HIV prevention method for more than four years, with most countries still using relatively expensive surgical procedures that require anaesthetic, at least a couple of health workers and a six-week healing period. However, several new devices could revolutionize the amount of time, labour and money involved, enabling countries to rapidly scale up their programmes. WHO has approved three devices the Gomco Clamp, the Mogen Clamp and the Plastibell for infant male circumcision, but none for adult male circumcision. In February 2011, the organization developed a framework for the clinical evaluation of devices for adult male circumcision. Some of the devices under investigation include: The Shang Ring Developed in China, the Shang Ring comprises an inner and outer ring; the foreskin is placed between them and cut off, leaving the glans exposed during the seven-day healing period, after which the device is removed. Clinical trials in China have found the device to be safe, and a pilot study in western Kenyas Homa Bay found six mild adverse events including skin injury, oedema and mild infection when the device was tested on 40 HIV-negative men. Several more studies on the Shang Ring are ongoing, including in Kenya and Uganda, on acceptability, safety and randomized controlled trials in Kenya and Zambia comparing it to surgical procedures. The PrePex Device - Developed in Israel, the PrePex uses two rings and an applicator to restrict blood supply to the foreskin, which is removed, together with the device, after seven days. This method requires no anaesthesia. A study of 40 men in Rwanda found one adverse event at removal of the device and a healing time of 17 days. More studies are ongoing and planned in Rwanda and Zimbabwe. The Rwandan government plans to scale up male circumcision using the PrePex device. The Tara KLamp - Developed by Gurcharan Singh in Malaysia, the Tara KLamp has been widely used there for the circumcision of boys, including in public sector hospitals and circumcision campaigns. The device clamps on the foreskin so that the blood supply is cut off, and after seven to 10 days the foreskin is supposed to fall off with the clamp, but sometimes the clamp has to be surgically removed. It has also been controversially promoted in Lesotho and South Africa. In 2009, a randomized controlled trial in Orange Farm, South Africa, found adverse events of 37 percent in the 35 men in the Tara KLamp study, against 3.4 percent in the 34 men in the surgical arm. Men circumcised using the KLamp also reported worse pain. The trial was stopped early due to the unacceptably high rate of adverse events, with the researchers noting that, given the high rates of adverse events in this study and the low number of available studies, we strongly caution against the use of the TK for young adults, and we recommend careful evaluation of the procedure when performed on children. Nevertheless, Zulu king Goodwill Zwelithini in 2009 endorsed the KLamp for use in the traditional circumcision of boys in KwaZulu-Natal. It was used in about a quarter of the 35,000 circumcisions conducted; little data has emerged on complications. South African activist group, the Treatment Action Campaign declined to endorse the KLamp, stating that it was simply too risky for use on male adults and should not be used in the public health system. In June 2011, the South African government announced that it would not be using the Tara KLamp as part of its official male circumcision scale-up. According to WHO, no further clinical studies of the Tara KLamp are planned. ROME, 25 July 2011 (PlusNews) [This report does not necessarily reflect the views of the United Nations]-----> Message 3 From: Gabriel ADEYEMO Subject: Coming soon: An improved, noiseless female condom Source:* East African* AUTHOR: Esther Nakkazi http://in2eastafrica.net/coming-soon-an-improved-noiseless-female-condom/ Dear GYCAers, An improved version of the female condom and a new vaginally-inserted contraceptive are among the latest innovations in female reproductive health. Scientists have come up with these improved versions to stem the high risk of sexually transmitted infections among women. According to Dr Christopher Elias president and chief executive of PATH, the global body that provides tailor-made health technologies, the development of such products begins in the field with potential users identifying problems of high HIV and pregnancy incidence. A new technology is then developed and tested in the community as consultations with governments are scaled up, Dr Elias said during the recent Pacific Health Summit. It is on this basis and the criticism that the original female condom drew that scientists have now improved the product, saying it is a simple to use reproductive health solution that, along with the Path-developed SILCS diaphragm offer women more prevention choices... The female condom is now under review by the World Health Organisation and the United Nations Population Fund (UNPFA) technical committees. Another product also under clinical validation is the SILCS diaphragm, used by women to prevent unwanted pregnancy and sexually transmitted infections... More information are available on the link above. -- Many Thanks Yours' in Prevention Science Gabriel, ADEYEMO Regional Focal Point - West Africa Global Youth Coalition on HIV/AID (GYCA) +234-80-6798-7317 \| gabriel (at) gyca.org www.gyca.org \| www.tigweb.org GYCA is a youth-led global network of more than 5,500 young leaders and adult allies working on youth and HIV/AIDS in over 173 countries world-wide. GYCA's mission is to empower young leaders with the skills, knowledge, resources and opportunities they need to scale up HIV/AIDS interventions amongst their peers. Universal Access is possible; * Zero new HIV infections. Zero discrimination and Zero AIDS-related deaths.*-----> Message 4 From: joya banerjee Subject: TED: Hans Rosling on the HIV epidemic An excellent and visually captivating TED Talk on the HIV epidemic- its beginnings, trends, relationship to income, treatment vs. prevention, and causes of high prevalence: Hans Rosling unveils new data visuals that untangle the complex risk factors of one of the world's deadliest (and most misunderstood) diseases: HIV. He argues that preventing transmissions -- not drug treatments -- is the key to ending the epidemic. http://www.ted.com/talks/hans_rosling_the_truth_about_hiv.html Joya-----> Message 5 From: "John Piermont V. Montilla" Subject: Help Dr. Arash Alaei and his brother Dr. Kamiar Alaei are renownedHIV/AIDS physician Dear GYCA Friends, As many of you know, one of the Asia 21 Young Leaders is currently being held in Teheran’s Evin Prison. Dr. Arash Alaei and his brother Dr. Kamiar Alaei are renowned HIV/AIDS physicians who were arrested in June 2008 and convicted in January 2009 on charges of communicating with an enemy government because they had traveled to international AIDS and public health conferences and worked with international health workers to help find solutions to the HIV/AIDS pandemic. In late 2010, Kamiar was released following 870 days in prison in Iran. Arash was sentenced to six years in prison and today remains behind bars after three long years. People from around the world are coming together to push for Arash’es release, and we Aisia Society Fellows are encouraged by our President Jamie Metzl to reach out to our networks and freinds on his behalf to urge you all to consider taking the following actions: 1. If you have not already done so, please sign the electronic petition at http://iranfreethedocs.org/petition/ 2. Please distribute the petition to your friends and encourage them to sign it. 3. Please consider sending a letter to the Iranian embassy in your country referencing your connection to Arash as part of the Asia 21 community and adapting some of the language from the petition as you see fit. Warmest regards to you all, John Piermont Montilla GYCA Philippines Asia 21 Young Leaders Fellow Phil21 Class of 2011 http://aidscompetence.ning.com/profiles/blogs/gangs-who-say- they-are-bad http://aidscompetence.ning.com/profiles/blogs/to-be-a-friend -a-salt-visit-----> Message 6 From: joya banerjee Subject: FW: Pregnancy increases risk of HIV : Message from Melanie Pleaner From: Susie Cornell [mailto:scornell (at) wrhi.ac.za] Sent: Monday, August 08, 2011 10:35 AM Please see article below, note the conclusion: The authors underscore the public health importance of these new findings showing pregnancy increases the risk of female-to-male transmission two-fold. New strategies, they add, are needed to strengthen family planning and maternal health services for women with and at risk for HIV in order to reduce unwanted pregnancies and avert HIV transmission to pregnant women and from pregnant women to their infants and partners. Regards Mel Melanie Pleaner PLEASE SEND ANY COMMUNICATIONS TO REPLIES TO CONTRACEPTION EXPERT MAILING GROUP TO mpleaner (at) mweb.co.za ________________________________ http://aidsmap.com/page/2033107/ Pregnancy doubled risk of female-to-male HIV transmission in Partners in Prevention study Carole Leach-Lemens Published: 05 August 2011 Pregnancy increased the risks of female-to-male HIV transmission two-fold among over 3300 serodiscordant couples from seven African countries Nelly R Mugo and colleagues reported in a prospective study published in the advance online edition of AIDS. The risks of becoming infected with HIV during pregnancy increased at the same rate. However, this was partly explained by other factors including unprotected sex. Women now account for 60% of HIV infections in adults in sub-Saharan Africa. Many African countries with high HIV prevalence also have high fertility rates and often women are pregnant for a considerable part of their adult lives. Pregnancy brings biological and behavioural changes that may make a woman more susceptible to getting HIV as well as making her more infectious, so increasing the risks of transmission. To date limited prospective studies have found inconsistent results, showing both an increased risk and no elevated risk of acquiring HIV during pregnancy. However, evidence shows that women infected during their pregnancy have a high rate of HIV transmission to their infants. The authors note one study which showed increased HIV shedding in genital secretions during pregnancy, suggesting increased infectiousness, yet no prospective study has looked specifically at pregnancy as a risk factor for female-to-male transmission. The authors chose to look at the association between pregnancy and the risks of getting HIV as well as the risks of transmitting HIV from females-to-males in a secondary analysis of a prospective study of African HIV sero-discordant couples. From November 2004 to April 2007 3408 HIV serodiscordant couples from Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda and Zambia were enrolled in the Partners in Prevention HSV-2/HIV transmission study, a randomised, placebo-controlled, clinical trial of aciclovir as herpes simplex virus-2 (HSV-2) suppressive therapy for the prevention of HIV transmission. Aciclovir did not decrease HIV transmission risk within the couples. Of the 3321 couples in the analysis about a third (1085) included an HIV-infected male partner and the remaining two-thirds (2236) included an HIV-infected female partner. Eligibility included being over 18 years of age, having three or more episodes of vaginal intercourse in the three months before screening and having the intention of remaining a couple. HIV infected partners were positive for HSV-2, had CD4 cell counts over 250 cells/mm3 and were not taking antiretrovirals. HIV-infected women pregnant at the screening were excluded from the study. Women who became pregnant stopped the study medication until the end of pregnancy. Pregnant HIV-uninfected women were included as were those who became pregnant during follow-up. HIV infected partners were seen monthly and HIV uninfected partners were seen every three months. Sexual behaviour data including condom use was recorded at each visit as was contraceptive use. Comprehensive prevention services included individual and couple HIV risk reduction counselling, quarterly syndromic management of sexually transmitted infection treatment and free condoms. The majority were married and living together. Median CD4 cell count was 461 cells/mm3. The couples were followed for up to 24 months; median time for HIV-negative and HIV-positive partners was 20.9 months (IQR: 15.6-24.1) and 19.9 months (IQR: 14.3-23.9), respectively. Of the 61 HIV seroconversions among women close to 30% (17) happened during pregnancy. HIV incidence during pregnancy was 7.35 per 100 person years compared to 3.01 per 100 person years during non-pregnant periods, (HR: 2.34, 95% CI: 1.33-4.09, p=0.003). Risk was high during both early and late pregnancy. However, in multivariate analysis after controlling for age, contraceptive use and unprotected sex, the effect of pregnancy on HIV risk was not statistically significant. Of the 58 HIV transmissions to men, 12 (20.7%) happened during pregnancy. The incidence of female-to-male transmission was 3.46 per 100 person years during pregnancy compared to 1.58 per 100 person-years when the female partner was not pregnant. This was statistically significant (HR 2.31, p=0.01) and remained significant after adjusting for confounding factors (HR.2.47, p=0.01). The authors underscore the public health importance of these new findings showing pregnancy increases the risk of female-to-male transmission two-fold. New strategies, they add, are needed to strengthen family planning and maternal health services for women with and at risk for HIV in order to reduce unwanted pregnancies and avert HIV transmission to pregnant women and from pregnant women to their infants and partners. Strengths of the study include a large sample size and multinational cohort. The study also established a genetic viral linkage of transmitted HIV within partnerships so minimising the potential for misclassification of female-to-male transmission. The authors note their findings can be generalised; all participants were co-infected with HSV-2 as are over 80% of all HIV infected adults in sub-Saharan Africa. The authors conclude increased risk for HIV female-to-male transmission during pregnancy requires further studies to understand the possible biologic mechanisms that may explain this finding. They add: Prenatal couples HIV counselling and testing, implementation of repeat HIV testing in pregnancy, and earlier initiation of combination ART should become part of routine antenatal care to protect mothers, infants and male partners from HIV. Reference Mulago NR et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1 serodiscordant couples. Advance online edition of AIDS 25, doi: 10.1097/QAD.0b013e32834a9338, 2011.